Human mast cell subsets - Distinct functions in inflammation?

Inflammation Research

Volumn 49, Issue 1, 2000, Pages 3-7

  McNeil, H P ^a   Gotis Graham, I ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Inflammation; Mast cell; Proteinase; Rheumatoid arthritis

Indexed keywords

CELL HYPERPLASIA; CELL SUBPOPULATION; CONNECTIVE TISSUE; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAST CELL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; TISSUE REPAIR;

EID: 0033957159     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012386     Document Type: Review

References (51)

1. [1] Caughey GH. The structure and airway biology of mast cell proteinases. Am J Respir Cell Mol Biol 1991; 4: 387-94.
2. [2] McNeil HP. The mast cell and inflammation. Aust N Z J Med 1996; 26: 216-25.
3. [3] Gaboury JP, Johnston B, Niu XF, Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995; 154: 804-13.
4. [4] Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994; 152: 3570-7.
5. [5] Wershil BK, Furuta GT, Wang ZS, Galli SJ. Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996; 110: 1482-90.
6. [6] Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule I. Proc Natl Acad Sci USA 1991; 88: 4220-4.
7. [7] Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996; 381: 77-80.
8. [8] Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75-7.
9. [9] Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340-3.
10. [10] Mecheri S, David B. Unravelling the mast cell dilemma: culprit or victim of its generosity? Immunol Today 1997; 18: 212-5.
11. [11] Liu FT. Truly MASTerful cells: mast cells command B cell IgE synthesis. J Clin Invest 1997; 99: 1465-6.
12. [12] Williams CM, Coleman JW. Induced expression of mRNA for IL-5, IL-6, TNF-α, MIP-2 and IFN-γ in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 1995; 86: 244-9.
13. [13] Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990; 346: 274-6.
14. [14] Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170: 245-57.
15. [15] Yano K, Yamguchi M, deMora F, Lantz CS, Butterfield JH, Costa JJ, et al. Production of macrophage inflammatory protein-1 alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 1997; 77: 185-93.
16. [16] Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, et al. Human mast cells produce IL-8. J Immunol 1993; 151: 3261-6.
17. [17] Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response. Immunol Today 1992; 13: 379-80.
18. [18] Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993; 151: 6318-28.
19. [19] Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 1994; 158: 253-64.
20. [20] Frandji P, Tkaczyk C, Oskeritzian C, Lapeyre J, Peronet R, David B, et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-γ. Cell Immunol 1995; 163: 37-46.
21. [21] Alber G, Kent UM, Metzger H. Functional comparison of FcεRI, FcγRII, and FcγRIII in mast cells. J Immunol 1992; 149: 2428-36.
22. [22] Katz HR, Raizman MB, Gartner CS, Scott HC, Benson AC, Austen KF. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. J Immunol 1992; 148: 868-71.
23. [23] Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 1994; 265: 1095-8.
24. [24] Ramos BF, Zhang Y, Jakschik BA. Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 1994; 152: 1380-4.
25. [25] Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 1996; 81: 68-73.
26. 4 from mouse bone marrow-derived mast cells. Eur J Pharmacol 1994; 257: 235-42.
27. [27] Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med 1992; 176: 781-6.
28. 3H]5HT release. Immunology 1995; 86: 434-40.
29. [29] Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994; 152: 1298-303.
30. [30] Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-8.
31. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37: 1509-15.
32. TC type of mast cell. J Immunol 1990; 145: 2652-61.
33. TC cells. J Immunol 1991; 147: 247-53.
34. [34] Irani AM, Craig SS, DeBlois G, Elson CO, Schechter NM, Schwartz LB. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987; 138: 4381-86.
35. TC) in cutaneous inflammation using novel enzyme-histochemical staining techniques. Exp Dermatol 1994; 3: 290-7.
36. T cells in the skin and evidence of mast cell activation. Arthritis Rheum 1992; 35: 933-9.
37. [37] Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155: 297-307.
38. [38] Trautmann A, Krohne G, Broker E-B, Klein CE. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J Immunol 1998; 160: 5053-7.
39. [39] Matin R, Tam EK, Nadel JA, Caughey GH. Distribution of chymase-containing mast cells in human bronchi. J Histochem Cytochem 1992; 40: 781-6.
40. [40] McNeil HP, Austen KF. Biology of the mast cell. In: Frank MM, Austen KF, Claman HN, Unanue ER, editors. 'Samter's' Immunological Diseases]. 5th Ed. Boston: Little Brown & Co., 1995; 185-204.
41. [41] Patella V, DeCrescenzo G, Ciccarelli A, Marino I, Adt M, Marone G. Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 1995; 106: 386-93.
42. [42] DePaulis A, Marino I, Ciccarelli A, DeCrescenzo G, Concardi M, Verga L, et al. Human synovial mast cells I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum 1996; 39: 1222-33.
43. TC subset with matrix turnover and clinical progression. Arthritis Rheum 1997; 40: 479-89.
44. [44] Gotis-Graham I, Smith MD, Parker A, McNeil HP. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 1998; 57: 664-71.
45. [45] Gruber BL, Schwanz LB, Ramamurthy NS, Irani AM, Marchese MJ. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 1988; 140: 3936-42.
46. [46] Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994; 269: 18134-40.
47. [47] Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147: 564-73.
48. [48] Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493-9.
49. [49] Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995; 270: 4689-96.
50. [50] Mayrhofer G, Bazin H. Nature of the thymus dependency of mucosal mast cells III. Mucosal mast cells in nude mice and nude rats, in B rats and in a child with Di George syndrome. Int Arch Allergy Applied Immunol 1981; 64: 320-31.
51. [51] Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 39-44.